ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: LISDEXANFETAMINA DIMESILATO (ELVANSE), FRUQUINTINIB (FRUZAQLA).
TED · 433502-2026Award noticeawardedNo deadline given
Buyer
NameServicio Madrileno de Salud, Hospital Universitario La Paz
CountryES
Published2026-06-25
Deadline—
Value
Estimated—
Awarded€40,213 · 40,213.21 EUR
WinnerTAKEDA FARMACEUTICA ESPAÑA, S.A.
Who already wins at this buyer
Firms with recorded awards from Servicio Madrileno de Salud, Hospital Universitario La Paz in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE FARMA, S.A.U. | 2 | €2,779,646 | 2026-06-15 |
| BRISTOL-MYERS SQUIBB, S.A.U. | 2 | €824,543 | 2026-06-29 |
| Abbott Medical España, S.A., | ANGIONAUTIX, S.L. | BALT SPAIN MEDICAL, S.L. | CARDIVA 2, S.L. | CORDIS MEDICAL SPAIN, S.L.U. | GRIFOLS MOVACO, S.A. | JOHNSON & JOHNSON, S.A. | MEDTRONIC IBERICA S.A. | MERCÉ V. ELECTROMEDICINA, S.L. | MERIT MEDICAL SPAIN S.L.U. | STRYKER IBERIA, S.L. | World Medica, S.L.U. | Terumo Europe España S.L. | 1 | €2,296,504 | 2026-06-30 |
| CSL BEHRING S.A. | 1 | €1,808,508 | 2026-05-20 |
| CHIESI ESPAÑA, S.A.U. | 1 | €535,432 | 2026-06-15 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: LISDEXANFETAMINA DIMESILATO (ELVANSE), FRUQUINTINIB (FRUZAQLA).
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-22 | ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: TRIFLURIDINA/TIPIRACILO (LONSURF). | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 92% |
| 2026-06-15 | SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: PEGUNIDALSIDASA (ELFABRIO), LEVOFLOXACINO INHALADO (QUINSAIR) Y SURFACTANTE PULMONAR PORCINO (CUROSURF) | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 91% |
| 2026-06-29 | ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: MAVACAMTEN (CAMZYOS), AZTREONAM (AZACTAM). | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 91% |
| 2026-06-09 | SUMINISTRO DEL MEDICAMENTO EXCLUSIVO: LEBRIKIZUMAB (EBGLYSS) | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 91% |
| 2026-05-04 | SUMINISTRO DEL MEDICAMENTO EXCLUSIVO: BLINATUMOMAB (BLINCYTO) | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 90% |
| 2026-05-29 | SUMINISTRO DE MEDICAMENTO EXCLUSIVO: SELADELPAR (LYVDELZI) | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 90% |